Performances on Cognitive Functions and Brain Function and Follow-up After Different Treatments in Patients With Autonomous Cortisol Secretion: a Single-center, Prospective, Observational Study

Sponsor
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School (Other)
Overall Status
Recruiting
CT.gov ID
NCT05357456
Collaborator
(none)
62
1
60
1

Study Details

Study Description

Brief Summary

This is a single center, prospective, observational study to explore and evaluate the differences on cognitive function and brain function by functional-MRI in autonomous cortisol secretion patients, and the different treatments methods on the cognitive function and brain function in patients with autonomous cortisol secretion

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Cognitive function assessment; functional magnetic resonance imaging
  • Procedure: laparoscopic adrenal surgery

Detailed Description

Glucocorticoids, mainly cortisol, play a crucial role in the allostatic process of adjustment to stressors and can determine important changes in central nervous system structures. It is well known that Cushing's syndrome (CS) is associated with neurocognitive impairment in about two-thirds of cases. In CS the most frequent reported alterations are memory impairment (about 83% of cases) and reduced concentration (66% of cases) . Unfortunately, these alterations are only partially reversible after the hypercortisolism resolution. As so far, data related to the impact of autonomous cortisol secretion (ACS) on cognitive function are scarce and lack of magnetic resonance indicators. Few studies have studied the cognitive function changes of patients with ACS by surgical and conservative treatment. In the single center, prospective and observational study we aim to explore cognitive functions and brain function by functional-MRI in adrenal incidentaloma patients in relation to the presence of ACS and, secondly, in a group of acs patients, the effect of adrenalectomy on cognitive functions and brain function.

Study Design

Study Type:
Observational
Anticipated Enrollment :
62 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
A Single Center, Prospective, Observational Study to Explore and Evaluate the Differences of Cognitive Function and Brain Function Between Non-functioning Adrenal Adenomas and Autonomous Cortisol Secretion Patients, and the Different Treatments Methods on Cognitive Function and Brain Function in Patients With Autonomous Cortisol Secretion
Actual Study Start Date :
Oct 1, 2021
Anticipated Primary Completion Date :
Oct 1, 2024
Anticipated Study Completion Date :
Oct 1, 2026

Arms and Interventions

Arm Intervention/Treatment
autonomous cortisol secretion

Patients admitted to the hospital with adrenal incidentalomas are evaluated for adrenal function, and then ACS patients are diagnosed based on the serum cortisol ≥ 50 nmol/L following the 1 mg dexamethasone suppression test and without any other signs or symptoms of cortisol excess.Patients with ACS will undergo a physical exam, cognitive function test as well as structural and functional brain MRI at baseline and 12 months after their surgery or conservative treatment.

Behavioral: Cognitive function assessment; functional magnetic resonance imaging
cognitive function measurement
Other Names:
  • fMRI
  • Procedure: laparoscopic adrenal surgery
    Only a subgroup of the autonomous cortisol secretion patients will have the laparoscopic adrenal surgery

    non-functioning adrenal adenomas

    Patients admitted to the hospital with adrenal incidentalomas are evaluated for adrenal function, and then non-functioning adrenal adenomas patients are diagnosed based on the serum cortisol < 50 nmol/L following the 1 mg dexamethasone suppression test .Patients with non-functioning adrenal adenomas will undergo a physical exam, cognitive function test as well as structural and functional brain MRI at baseline.

    Behavioral: Cognitive function assessment; functional magnetic resonance imaging
    cognitive function measurement
    Other Names:
  • fMRI
  • Outcome Measures

    Primary Outcome Measures

    1. Participants' personal information [1 day]

      Self-reported information(education in years)

    2. Physical assessments [1 day]

      BMI(body mess index) in kg/m^2

    3. Imaging examinations [1 day]

      Adrenal adenoma size in cm

    4. Montreal Cognitive Assessment (MoCA) [20 minutes]

      The MoCA is a Global cognitive screening test designed to assist Health Professionals in detection of mild cognitive impairment.

    5. Mini-Mental State Examination (MMSE) [20 minutes]

      The MMSE is a cognitive screening test designed to assist Health Professionals in detection of mild cognitive impairment.

    6. Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) [1 hour]

      The RBANS is a cognitive screening test designed to assist Health Professionals in evaluation of multiple cognitive subdomains

    7. Rest Functional MRI of the brain function. [40 minutes]

      Rs-fMRI

    8. Screening for adrenal cortisol hypersecretion [1 day]

      Patients were given 1 mg dexamethasone orally at 24:00 am, and the cortisol levels were measured at 8:00 am the following morning

    Secondary Outcome Measures

    1. Changes from basline global cognitive functions [12 months after the laparoscopic adrenal surgery (for patients with autonomous cortisol secretion who are willing to operate)]]

      MoCA

    2. Changes from basline multiple cognitive subdomains [12 months after the laparoscopic adrenal surgery (for patients with autonomous cortisol secretion who are willing to operate)]]

      RBANS

    3. Change from baseline Functional magnetic resonance imagine [12 months after the laparoscopic adrenal surgery (for patients with autonomous cortisol secretion who are willing to operate)]]

      Rs-fMRI

    4. Changes from basline global cognitive functions [12 months after the conservative treatment (for patients with autonomous cortisol secretion who are not willing to operate)]]

      MoCA

    5. Changes from basline multiple cognitive subdomains [12 months after the conservative treatment (for patients with autonomous cortisol secretion who are not willing to operate)]]

      RBANS

    6. Change from baseline Functional magnetic resonance imagine [12 months after the conservative treatment (for patients with autonomous cortisol secretion who are not willing to operate)]]

      Rs-fMRI

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    20 Years to 65 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • age 20-65 years;

    • ≥ 6 years of education;

    • right-handed;

    • complete entire cognitive function tests;

    • adrenal lesions ≥ 1 cm in diameter;

    • patients with non-functioning adrenal adenomas;

    • patients with autonomous cortisol secretion.

    Exclusion Criteria:
    • < 6 years of education;

    • age < 20 years or > 65 years;

    • maximum diameter of AI <1cm;

    • active malignancies;

    • with a history of thyroid disease;

    • with a history of acute infection in the last month;

    • central nervous system diseases, including brain trauma, intracranial hemorrhage, acute cerebral infarction, etc;

    • contraindications of MRI examination: such as implantation of metal prosthesis in vivo, claustrophobia, etc;

    • adrenal tuberculosis;

    • suspected or diagnosed adrenocortical carcinoma;

    • unable to complete entire cognitive function tests;

    • current use of steroids or any drugs known to alter steroid synthesis or metabolism in the previous 3 months;

    • clinical Cushing syndrome;

    • Cushing disease;

    • primary hyperaldosteronism;

    • pheochromocytoma;

    • severe impairment of heart, liver, kidney and other organs;

    • pregnant and lactating women

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Department of Endocrinology, Drum Tower Hospital affiliated to Nanjing University Medical School Nanjing Jiangsu China 210008

    Sponsors and Collaborators

    • The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

    Investigators

    • Principal Investigator: Dalong Zhu, MD,PhD, The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Dalong Zhu, Chief Physician, The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
    ClinicalTrials.gov Identifier:
    NCT05357456
    Other Study ID Numbers:
    • LP2022
    First Posted:
    May 2, 2022
    Last Update Posted:
    May 2, 2022
    Last Verified:
    Apr 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    Undecided
    Plan to Share IPD:
    Undecided
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Dalong Zhu, Chief Physician, The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of May 2, 2022